
Progress in Medicinal Chemistry
- 1st Edition, Volume 45 - February 19, 2007
- Editors: F.D. King, G. Lawton
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 4 - 5 2 8 0 8 - 7
- Paperback ISBN:9 7 8 - 0 - 4 4 4 - 5 6 1 0 0 - 8
- eBook ISBN:9 7 8 - 0 - 0 8 - 0 4 7 1 3 1 - 0
The success of any drug discovery project relies upon the quality of the lead that initiates the lead optimization process. What defines a ‘quality lead’, where these ‘quality… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quote*Publishes on an annual basis to bring you the most innovative updates in medicinal chemistry
*Available as an online resource via ScienceDirect
- No. of pages: 232
- Language: English
- Edition: 1
- Volume: 45
- Published: February 19, 2007
- Imprint: Elsevier Science
- Hardback ISBN: 9780444528087
- Paperback ISBN: 9780444561008
- eBook ISBN: 9780080471310
FK
F.D. King
GL
G. Lawton
From 2003 to 2007 he was founding Research Director with Lectus Therapeutics building from start-up a drug discovery organisation; generating the team, facilities and project portfolio targeting the next generation of ion channel modulating medicines.
Since 2001 Geoff has provided scientific and strategic evaluation and advice on drug discovery as an independent consultant for a number small and medium sized biotech companies, CROs, VCs, academic groups and medical research charities.
Geoff serves on the Board of Antabio, a French biotech company developing tomorrow’s antibacterial drugs.
He is a founder of INMedD, a new medicines discovery social enterprise.